Download
|
< Back |
| 07:06 PM | |
| Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we hereby inform that Company has announced the launch of its next generation 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - valent (PCV20) for adults in India, on August 11, 2025. | |
| View all announcements for Pfizer Ltd | Source: BSE India |